Prevention of nonalcoholic steatohepatitis in rats by two manganese-salen complexes

Iranian Biomedical Journal

Volumn 18, Issue 1, 2013, Pages 41-48

  Rezazadeh, Alireza ^a   Yazdanparast, Razieh ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Antioxidants; Fatty liver; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ANTIOXIDANT; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CATALASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MANGANESE 3 METHOXY N,N' BIS(SALICYLDENE)ETHYLENEDIAMINE CHLORIDE; MANGANESE DERIVATIVE; MANGANESE N,N' BIS(SALICYLDENE)ETHYLENEDIAMINE CHLORIDE; MANGANESE N,N' ETHYLENEBIS(3 METHOXYSALICYLIDENEAMINE); MANGANESE SALEN CHLORIDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CHELATING AGENT; CHOLINE; DISALICYLALDEHYDE ETHYLENEDIAMINE; ETHYLENEDIAMINE DERIVATIVE; METHIONINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER WEIGHT; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; RAT; ANIMAL; DIET; DRUG EFFECTS; FATTY LIVER; IMMUNOLOGY; INFLAMMATION; LIVER; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CHELATING AGENTS; CHOLINE; DIET; ETHYLENEDIAMINES; FATTY LIVER; INFLAMMATION; LIVER; MALE; MANGANESE COMPOUNDS; METHIONINE; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; RATS;

EID: 84888785787     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/ibj.1201.2013     Document Type: Article

References (35)

1. Wong VW. Nonalcoholic fatty liver disease in Asia: A story of growth. J Gastroenterol Hepatol. 2013 Jan; 28(1): 18-23.
2. Begriche K, Knockaert L, Massart J, Robin M, Fromenty B. Mitochondrial dysfunction in nonalcoholic steatohepatitis (NASH): are there drugs able to improve it? Drug Discov Today Dis Mech. 2009; 6(1):e11-e23.
3. Persico M, Masarone M. Indirect markers of nonalcoholic fatty liver disease: Another piece of the puzzle? Dig Liver Dis. 2010 Dec; 42(12):846-7.
4. Kirpich IA, Gobejishvili L, Homme M, Waigel S, Cave M, Arteel G, et al. Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. J Nutr Biochem. 2011 Jan; 22(1):38-45.
5. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion. 2006 Feb; 6(1):1-28.
6. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: A review and update. Dig Dis Sci. 2010 Mar; 55(3):560-78.
7. Rolo A, Teodoro J, Palmeira C. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med. 2012 Jan; 52(1): 59-69.
8. Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis. 2010 May; 42(5):320-30.
9. Amini R, Nosrati N, Yazdanparast R, Molaei M. Teucrium polium in prevention of steatohepatitis in rats. Liver Int. 2009 Sep; 29(8):1216-21.
10. Le T, Loomba R. Management of non-alcoholic fatty liver disease and steatohepatitis. J Clin Exp Hepatol. 2012; 2(2): 156-73.
11. Bafana A, Dutt S, Kumar A, Kumar S, Ahuja PS. The basic and applied aspects of superoxide dismutase. J Mol Cat B Enzym. 2011; 68(2):129-38.
12. Batinić-Haberle I, Rebouças J, Spasojević I. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid Redox Signal. 2010 Sep; 13(6):877-918.
13. Baker K, Marcus CB, Huffman K, Kruk H, Malfroy B, Doctrow SR. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther. 1998 Jan; 284(1):215-21.
14. Xu ZS, Jung CW, Rong YQ, Doctrow S, Baudry M, Malfroy B. Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model. Neurosci Lett. 2001 May; 304(3):157-60.
15. Ustundag B, Bahcecioglu IH, Sahin K, Duzgun S, Koca S, Gulcu F, et al. Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model. Dig Dis Sci. 2007 Aug; 52(8):2006-14.
16. Khan A, Nafees S, Sultana S. Perillyl alcohol protects against ethanol induced acute liver injury inWistar rats by inhibiting oxidative stress, NFκ-B activation and proinflammatory cytokine production. Toxicology. 2011 Jan; 279(1-3):108-14.
17. Rashid K, Das J, Sil P. Taurine ameliorate alloxan induced oxidative stress and intrinsic apoptotic pathway in the hepatic tissue of diabetic rats. Food Chem Toxicol. 2013 Jan; 51:317-29.
18. Waseem M, Parvez S. Mitochondrial dysfunction mediated cisplatin induced toxicity: Modulatory role of curcumin. Food Chem Toxicol. 2013 Mar; 53: 334-42.
19. Łuczaj W, Stankiewicz-Kranc A, Milewska E, Roszkowska-Jakimiec W, Skrzydlewska E. Effect of sweet grass extract against oxidative stress in rat liver and serum. Food Chem Toxicol. 2012 Feb; 50(2):135-40.
20. Ardestani A, Yazdanparast R. Antioxidant and free radical scavenging potential of Achilleasantolina extracts. Food Chem. 2007; 104(1):21-9.
21. Laurent A, Nicco C, Tran Van Nhieu J, Borderie D, Chereau C, Conti F, et al. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology. 2004 May; 39(5): 1277-85.
22. Ariz U, Mato JM, Lu SC, Chantar ML. Nonalcoholic steatohepatitis, animal models and biomarkers: what is new? Methods Mol Biol. 2010; 593:109-36.
23. Pelz S, Stock P, Brückner S, Christ B. A methioninecholine-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation. Exp Cell Res. 2012 Feb; 318(3): 276-87.
24. Kuiper HC, Bruno RS, Traber MG, Stevens JF. Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans. Free Radic Biol Med. 2011 Apr; 50(7):848-53.
25. Yazdanparast R, Bahramikia S, Ardestani A. Nasturtium officinale reduces oxidative stress and enhances antioxidant capacity in hypercholesterolaemic rats. Chem Biol Interact. 2008 Apr; 172(3):176-84.
26. Nosrati N, Aghazadeh S, Yazdanparast R. Effects of Teucriumpoliumon insulin resistance in nonalcoholic steatohepatitis. J Acupunct Meridian Stud. 2010 Jun; 3(2):104-10.
27. Oliveira CP, Gayotto LC, Tatai C, Della Nina BI, Lima ES, Abdalla DS, et al. Vitamin C and vitamin E in prevention of nonalcoholic fatty liver disease (NAFLD) in choline deficient diet fed rats. Nutr J. 2003 Oct;2:9.
28. Fernandez ML, Vega S, Ayala MT, Shen H, Conde K, Vergara Jimenez M, et al. Vitamin C level and dietary fat saturation alter hepatic cholesterol homeostasis and plasma LDL metabolism in guinea pigs. J Nutr Biochem. 1997; 8(7):414-24.
29. Samsam Shariat SZ, Mostafavi SA, Khakpour F. Antioxidant effects of vitamins C and E on the lowdensity lipoprotein oxidation mediated by yeloperoxidase. Iran Biomed J. 2013; 17(1):22-8.
30. Yoshida H, Kisugi R. Mechanisms of LDL oxidation. Clin Chim Acta. 2010 Dec; 411(23-24):1875-82.
31. Ali W, Ahmad I, Usman K, Kumar S. Anti-atherogenic functions of high density lipoporoteins. IJPMBS. 2013 Jan; 2 (1): 17-26.
32. Tsompanidi EM, Brinkmeier MS, Fotiadou EH, Giakoumi SM, Kypreos KE. HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Atherosclerosis. 2010 Jan; 208:3-9.
33. Okamoto K. Vitamin C intake and apolipoproteins in a healthy elderly Japanese population. Prev Med. 2002 Mar; 34(3):364-9.
34. Segal AW. The function of the NADPH oxidase of phagocytes and its relationship to other NOXs in plants, invertebrates, and mammals. Int J Biochem Cell Biol. 2008; 40(4):604-18.
35. Sam C, Lu H. The role of hypochlorous acid as one of the reactive oxygen species in periodontal disease. J Dent Sci. 2009; 4(2):45-54.